Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review - PubMed (original) (raw)
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review
Helena C Chui et al. Alzheimers Res Ther. 2012.
Abstract
Recent epidemiologic studies have noted that risk factors for atherosclerosis (for example, diabetes mellitus, hypertension, and hyperlipidemia) are associated with increased risk of incident Alzheimer's disease (AD). In this evidence-based review, we frame the proposition as a question: are vascular risk factors also risk factors for plaques and tangles or just for concomitant vascular pathology that increases the likelihood of dementia? To date, no representative, prospective studies with autopsy (evidence level A) show significant positive associations between diabetes mellitus, hypertension, or intracranial atherosclerosis and plaques or tangles. Some prospective, representative, epidemiologic studies (evidence level B) show associations between diabetes, hypertension, hyperlipidemia, and aggregated risk factors with clinically diagnosed incident AD. However, the strength of association diminishes in the following order: vascular dementia (VaD) > AD + VaD > AD. This pattern is arguably more consistent with the hypothesis that atherosclerosis promotes subclinical vascular brain injury, thereby increasing the likelihood of dementia and in some cases making symptoms present earlier. Several autopsy studies from AD brain banks (evidence level C) have observed positive associations between intracranial atherosclerosis and severity of plaques and tangles. However, these studies may reflect selection bias; these associations are not confirmed when cases are drawn from non-dementia settings. We conclude that, at the present time, there is no consistent body of evidence to show that vascular risk factors increase AD pathology.
Figures
Figure 1
Graph showing two alternative explanations. Do vascular risk factors (VRF) increase the probability of dementia by increasing plaques and tangles (arrows) or through subclinical infarcts (INF) (red line)? AD, Alzheimer's disease.
Figure 2
Sampling frame for convenience sample of Alzheimer's disease subjects and normal controls. Green shows two samples of normal controls (CN): CN1 is highly selected and CN2 is randomly sampled. In a cohort of Alzheimer's disease subjects (AD) and CN1, an association will be found between arteriosclerosis and Alzheimer's disease. In a cohort of AD and CN2, no such association will be found.
Figure 3
Sampling frame for a longitudinal aging cohort. An aging cohort study includes normal controls and subjects with Alzheimer's disease (AD) and stroke. The severity of arteriosclerosis and vascular risk factors are randomly sampled and representative for each group.
Figure 4
Sampling frame for a longitudinal aging cohort. At baseline examination, prevalent cases of stroke and Alzheimer's disease (AD) are identified and excluded from longitudinal follow-up.
Figure 5
Sampling frame for a longitudinal aging cohort. Prospective longitudinal follow-up allows estimation of new incident cases of stroke and Alzheimer's disease (AD). In ideal circumstances, it also allows the collection of a representative autopsy sample.
Similar articles
- Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.
Javanshiri K, Waldö ML, Friberg N, Sjövall F, Wickerström K, Haglund M, Englund E. Javanshiri K, et al. J Alzheimers Dis. 2018;65(4):1247-1258. doi: 10.3233/JAD-180644. J Alzheimers Dis. 2018. PMID: 30149459 - Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles.
Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, Walker DG, Roher AE. Beach TG, et al. Acta Neuropathol. 2007 Jan;113(1):13-21. doi: 10.1007/s00401-006-0136-y. Epub 2006 Sep 20. Acta Neuropathol. 2007. PMID: 17021755 - Links between the pathology of Alzheimer's disease and vascular dementia.
Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, Wisniewski T. Sadowski M, et al. Neurochem Res. 2004 Jun;29(6):1257-66. doi: 10.1023/b:nere.0000023612.66691.e6. Neurochem Res. 2004. PMID: 15176482 - Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
de la Torre JC. de la Torre JC. Neurol Res. 2004 Jul;26(5):517-24. doi: 10.1179/016164104225016254. Neurol Res. 2004. PMID: 15265269 Review. - Vascular dementia: atherosclerosis, cognition and Alzheimer's disease.
OBrien RJ. OBrien RJ. Curr Alzheimer Res. 2011 Jun;8(4):341-4. doi: 10.2174/156720511795745267. Curr Alzheimer Res. 2011. PMID: 21557721 Review.
Cited by
- Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.
Weissberger GH, Gollan TH, Bondi MW, Nation DA, Hansen LA, Galasko D, Salmon DP. Weissberger GH, et al. J Alzheimers Dis. 2019;67(1):291-302. doi: 10.3233/JAD-180351. J Alzheimers Dis. 2019. PMID: 30636736 Free PMC article. - Diabetes is Not Associated with Alzheimer's Disease Neuropathology.
Dos Santos Matioli MNP, Suemoto CK, Rodriguez RD, Farias DS, da Silva MM, Leite REP, Ferretti-Rebustini REL, Farfel JM, Pasqualucci CA, Jacob Filho W, Arvanitakis Z, Naslavsky MS, Zatz M, Grinberg LT, Nitrini R. Dos Santos Matioli MNP, et al. J Alzheimers Dis. 2017;60(3):1035-1043. doi: 10.3233/JAD-170179. J Alzheimers Dis. 2017. PMID: 28984587 Free PMC article. - Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors.
Raman MR, Kantarci K, Murray ME, Jack CR Jr, Vemuri P. Raman MR, et al. Alzheimers Dement (Amst). 2016 Dec 18;5:5-14. doi: 10.1016/j.dadm.2016.12.006. eCollection 2016. Alzheimers Dement (Amst). 2016. PMID: 28054023 Free PMC article. Review. - Effect of S-equol and Soy Isoflavones on Heart and Brain.
Sekikawa A, Ihara M, Lopez O, Kakuta C, Lopresti B, Higashiyama A, Aizenstein H, Chang YF, Mathis C, Miyamoto Y, Kuller L, Cui C. Sekikawa A, et al. Curr Cardiol Rev. 2019;15(2):114-135. doi: 10.2174/1573403X15666181205104717. Curr Cardiol Rev. 2019. PMID: 30516108 Free PMC article. Review. - Use of fish oil supplements is differently related to incidence of all-cause and vascular dementia among people with the distinct APOE ε4 dosage.
Ma H, Zhou T, Li X, Heianza Y, Qi L. Ma H, et al. Clin Nutr. 2022 Mar;41(3):731-736. doi: 10.1016/j.clnu.2022.01.019. Epub 2022 Feb 3. Clin Nutr. 2022. PMID: 35172255 Free PMC article.
References
- Qiu C, Xu W, Winblad B, Fratiglioni L. Vascular risk profiles for dementia and Alzheimer's disease in very old people: a population-based longitudinal study. J Alzheimer's Dis. 2010;20:293–300. - PubMed
- Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997;18(4 Suppl):S1–2. - PubMed
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources